Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the stock exchanges that its trading window will be closed from Wednesday, 1st October 2025 until 48 hours after the declaration of its financial results for the second quarter and half year ended 30th September 2025. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal insider trading code. During this period, insiders and designated persons will not be allowed to trade in the company's shares. This is a routine compliance measure typically taken ahead of results announcements to prevent insider trading.
No direct impact on the stock price or shareholders. This is a standard regulatory disclosure indicating that Q2 FY26 results are expected to be announced in the coming weeks, which investors should watch for as it will provide insight into the company's quarterly performance.